CDK2-dependent activation of PARP-1 is required for hormonal gene regulation in breast cancer cells.
about
Integration of Signaling Pathways with the Epigenetic Machinery in the Maintenance of Stem CellsADP-ribose-derived nuclear ATP synthesis by NUDIX5 is required for chromatin remodelingOverexpression of DOC-1R inhibits cell cycle G1/S transition by repressing CDK2 expression and activationCyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cellsMapping of six somatic linker histone H1 variants in human breast cancer cells uncovers specific features of H1.2.A critical role of CDKN3 in Bcr-Abl-mediated tumorigenesisProgesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells.LRP in Endothelial Cells: A Little Goes a Long Way.Differential Regulation of Progesterone Receptor-Mediated Transcription by CDK2 and DNA-PKLinking DNA Damage and Hormone Signaling Pathways in Cancer.ARTD1 regulates cyclin E expression and consequently cell-cycle re-entry and G1/S progression in T24 bladder carcinoma cells.Phosphorylation: a fundamental regulator of steroid receptor action.Beyond DNA Repair: Additional Functions of PARP-1 in Cancer.Macro domains as metabolite sensors on chromatin.More help than hindrance: nucleosomes aid transcriptional regulation.Transcriptional roles of PARP1 in cancer.TADs as modular and dynamic units for gene regulation by hormones.Role of PARP-1 in prostate cancer.A new role for an old player: steroid receptor RNA Activator (SRA) represses hormone inducible genes.BERing the burden of damage: Pathway crosstalk and posttranslational modification of base excision repair proteins regulate DNA damage management.Therapeutic Targeting of Poly(ADP-Ribose) Polymerase-1 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities.ATM induces MacroD2 nuclear export upon DNA damageHormone-induced repression of genes requires BRG1-mediated H1.2 deposition at target promoters.Insight into the machinery that oils chromatin dynamics.Post-translational modifications of the intrinsically disordered terminal domains of histone H1: effects on secondary structure and chromatin dynamics.Distinct structural transitions of chromatin topological domains correlate with coordinated hormone-induced gene regulation.Dynamics and dispensability of variant-specific histone H1 Lys-26/Ser-27 and Thr-165 post-translational modifications.Unliganded progesterone receptor-mediated targeting of an RNA-containing repressive complex silences a subset of hormone-inducible genesActivation of mitogen- and stress-activated kinase 1 is required for proliferation of breast cancer cells in response to estrogens or progestins.DNA damage and gene transcription: accident or necessity?Identifying Direct Protein Targets of Poly-ADP-Ribose Polymerases (PARPs) Using Engineered PARP Variants-Orthogonal Nicotinamide Adenine Dinucleotide (NAD+) Analog Pairs.Novel insights into the neuroendocrine control of inflammation: the role of GR and PARP1.PARty promoters: hormone-dependent gene regulation requires CDK2 activation of PARP1.Variations in the mRNA expression of poly(ADP-ribose) polymerases, poly(ADP-ribose) glycohydrolase and ADP-ribosylhydrolase 3 in breast tumors and impact on clinical outcome.The HSF1-PARP13-PARP1 complex facilitates DNA repair and promotes mammary tumorigenesis.Barcelona conference on epigenetics and cancer 2016 - beyond cancer genomes.Signaling by Steroid Hormones in the 3D Nuclear Space.Role of novel histone modifications in cancer.PARP1 promoter links cell cycle progression with adaptation to oxidative environment.
P2860
Q26769986-656F9D0B-11D2-4311-AE43-148EA01533E6Q28114985-DCC8F3BB-D0DC-44F7-8B85-11C5E97621CFQ28941776-C719F106-C5DE-45F2-9FFB-D0D89CEB383EQ34362853-6A747FEA-4DA9-48B5-8B91-AB6C61018A0FQ34400888-7CADC690-5767-4163-A822-1E1B4CDADF9FQ34435100-A424C113-CB27-469F-83C3-A39415AC2A8FQ35113788-F449A5F5-8060-4241-B8A8-F7693356B85FQ36519473-BD4E93C3-315F-4020-AD05-726E0117D843Q36688106-E1A7FBD8-0806-46A4-A870-896F003E353AQ36730819-B6882FFD-E0CC-4C99-A19D-9D95B6754475Q37143195-94C2415F-C9C7-47BB-A5B5-AB4CC0340CA1Q37198642-394FA17B-835E-4344-B588-BDD12EB6F9A1Q37346306-36D659BC-507F-48BF-AF11-FCC5F7B421D5Q38086003-C79C488C-1176-4705-98F7-6C79513E58FCQ38113645-C7E2DAD4-4853-452F-92DB-11DB1F6B81F7Q38219235-E0D2C2D2-AF6F-4A3F-A935-15F7BDA97CACQ38503197-32FFDA2C-603F-490C-AA35-A792E2E99BF8Q38526322-CE637A5D-4695-4286-8B26-D7F4C15C2724Q38636544-4EBD5679-1811-4B43-9164-4E2A915A9247Q38669183-E0A70AF6-B9A9-4C51-A212-A8561E3C1DFAQ38683171-504E7CB8-756C-44BF-848C-E7AC564014F3Q38722174-33F2CA06-F127-4378-93DA-8B20DAF9F270Q38759210-33B3087C-DC68-4F16-A5A1-8ACC103A825EQ38789935-31F16B69-F55B-4893-942D-31A9594A7B10Q38813372-77A4C503-609F-432E-9CDB-C102987BEC8DQ38951482-B5BDB3A8-96AC-4181-B2BF-79792591FE14Q38990534-8D767A90-F363-41BE-A1EF-B1DCB0F3D3A4Q39148484-ACD46507-9A95-43D0-ADD7-0987B4580BE3Q39162952-5038A2A3-AE57-492B-8ED7-DFACD88B3D5CQ41340286-97D1FDC0-6F3E-43C7-8E30-7E4FD6EFD511Q41910306-469416D4-1BC1-47F6-AF70-EA7DF712D692Q42781123-33DE347B-05A1-41FC-BEBD-AAF7CEBA58C0Q42939887-CB2D248E-353C-4876-B7E6-6519F727F9E1Q44542715-BC8F6755-E0B1-48F0-BFEF-AA8FB0CCB9B1Q47136688-5ED42AA2-563B-49C7-88B5-31BD23F908D5Q47577915-FEE5F5F4-84B6-4FD6-8160-04ACB432E9A7Q48184878-59928DDD-05A1-4C2B-904A-26E1F7488653Q52655031-5785CED4-7231-4F88-8255-D0BFCB2885A1Q55312472-1B8AFEE1-28DF-404B-BCAA-A7001D47E4CA
P2860
CDK2-dependent activation of PARP-1 is required for hormonal gene regulation in breast cancer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
CDK2-dependent activation of P ...... lation in breast cancer cells.
@ast
CDK2-dependent activation of P ...... lation in breast cancer cells.
@en
type
label
CDK2-dependent activation of P ...... lation in breast cancer cells.
@ast
CDK2-dependent activation of P ...... lation in breast cancer cells.
@en
prefLabel
CDK2-dependent activation of P ...... lation in breast cancer cells.
@ast
CDK2-dependent activation of P ...... lation in breast cancer cells.
@en
P2093
P2860
P50
P356
P1433
P1476
CDK2-dependent activation of P ...... ulation in breast cancer cells
@en
P2093
A Silvina Nacht
Baldo Oliva
Daniel Soronellas
Francois Le Dily
P2860
P304
P356
10.1101/GAD.193193.112
P50
P577
2012-09-01T00:00:00Z